Non-Invasive Prenatal Testing Market
Non-Invasive Prenatal Testing Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Non-Invasive Prenatal Testing Market Size and Growth
The Non-Invasive Prenatal Testing (NIPT) market is experiencing robust growth, driven by rising demand for early disease detection and advancements in testing technology. As of 2023, the market size is estimated at approximately $5 billion, with projections indicating significant expansion due to increased awareness and prenatal care investment globally. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Sequenom
◍ Roche
◍ Natera
◍ LabCorp
◍ BGI Genomics
◍ Quest Diagnostics
◍ Illumina
◍ Berry Genomics
The Non-Invasive Prenatal Testing market features key players like Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, and Berry Genomics. These companies innovate and expand testing technologies, enhance accessibility, and improve accuracy, driving market growth. Notable revenue figures include:
- Natera: $357 million
- Roche: $63 billion
- Illumina: $4.5 billion
Request Sample Report
Market Segmentation
By Application
0-12 Weeks
13-24 Weeks
25-36 Weeks
Request Sample Report
By Product
Market Growth
Request Sample Report
$ X Billion USD
